Rob Stein
๐ค SpeakerAppearances Over Time
Podcast Appearances
Scientists hope their work will help more people have healthy babies, but the experiments raise many ethical concerns, including using human embryos for research and the possibility that someday the technology could enable babies to develop completely outside the human body.
The FDA approved a new form of the weight loss drug Wegovi that people can take as a daily pill.
Until now, these so-called GLP-1 drugs for obesity could only be taken as weekly injections.
The Wegovi pill seems to work about as well as the Wegovi shot.
The pill will become available early next month.
The starting dose will cost about $149 a month for patients paying out of pocket, which is less than the shots.
GLP-1 drugs mimic a natural hormone that makes people feel full and have revolutionized the treatment of obesity.
A competing GLP-1 pill is expected to be approved soon.
Researchers in the U.S., China, and the U.K.
say they have used human cells from the lining of uteruses to create what they say can be called wombs on a chip and already use them to gain new insights into how human embryos implant in a womb.
Scientists hope their work will help more people have healthy babies, but the experiments raise many ethical concerns, including using human embryos for research and the possibility that someday the technology could enable babies to develop completely outside the human body.
New York, Louisiana, and Colorado are already getting slammed by the flu, and flu activity is increasing throughout the country.
Some experts worry the U.S.
may be in for another bad flu season.
Part of the reason is that the dominant flu strain recently mutated.
The mutated virus doesn't appear to make people sicker, but it does appear to spread more easily.
That means more people could get sick and get seriously ill.